2VOUSDEN K H. Outcomes of p53 activation - spoilt for choice[J].J Cell Sci, 2006, 119(Pt24) : 5015 -5020.
3BOURDON J C. P53 and its isoforms in cancer[ J].Br J Cancer,2007,97(3) : 277 -282.
4CHEUNG K J, HORSMAN D E, GASCOYNE R D. The signifi-cance of TP53 in lymphoid malignancies : mutation prevalence,regulation, prognostic impact and potential as a therapeutic target[J].Br J Haematol, 2009, 146(3) : 257 -269.
5CHIEN W P, WONG R H, CHENG Y W, et al. Associations ofMDM2 SNP309,transcriptional activity,mRNA expression,andsurvival in stage I non - small - cell lung cancer patients withwild - type p53 tumors [ J ].Ann Surg Oncol, 2010, 17(4):1194-1202.
6M0LLER M B, NIELSEN 0,PEDERSEN N T. Frequent altera-tion of MDM2 and p53 in the molecular progression of recurringnon - Hodgkin's lymphoma[ J].Histopathology, 2002, 41(4):322 -330.
7WANG P, LUSHNIKOVA T,ODVODY J, et al. Elevated Mdm2expression induces chromosomal instability and confers a survivaland growth advantage to B cells[ J].Oncogene,2008,27 ( 11):1590-1598.
8YANAMOTO S, KAWASAKI G, YOSHITOMI I, et al. P53,MDM -2 , and p21 expression in oral squemous cell carcinomas:Relationship with clinicopathologic factors [ J ].Oral Surg OralMed Oral Pathol Oral Radiol Endoc, 2002,94(5) : 593 -600.
9PINHEIRO G S,SILVA M R,RODRIGUES C A, et al. Prolifera-ting cell nuclear antigen (PCNA),p53 and MDM2 expression inHodgkins disease[ J].Sao Paulo Med J, 2007, 125(2) : 77 - 84.
10GAMBOA DOMINGUEZ A, SEIDL S,REYE GUTIERREZ E,etal. Prognostic significance of p21 WAF1/CIP1,p27Kipl,p53 andE - cadherin expression in gastric cancer [ J ].J Clin Pathol,2007,60(7) : 756 -761.
